Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice-Reference-Cited by-同舟云学术

Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice

Published:1998-11 Issue:11 Volume:4 Page:1253-1260
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Brown Michael P.,Topham David J.,Sangster Mark Y.,Zhao Jingfeng,Flynn Kirsten J.,Surman Sherri L.,Woodland David L.,Doherty Peter C.,Farr Andrew G.,Pattengale Paul K.,Brenner Malcolm K.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1198_1253.pdf

Reference52 articles.

1. Dunn, R.J., Luedecker, C.J., Haugen, H.S., Clegg, C.H., & Farr, A.G. Thymic overexpression of CD40 ligand disrupts normal thymic epithelial organization. J. Histochem. Cytochem. 45, 129-141 (1997 ).

2. van Kooten. C. & Banchereau, J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61, 1-77 (1996).

3. Hasbold, J., Johnson-Leger, C., Atkins, C.J., Clark, E.A. & Klaus, G.B. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24, 1835-1842 (1994).

4. Grewal, I.S. & Flavell, R.A. The CD40 ligand - at the center of the immune universe? Immunol. Res. 16, 59-70 (1997).

5. Stout, R.D. & Suttles, J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today 17, 487-492 (1996).

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome;Molecular Therapy - Methods & Clinical Development;2024-09

2. What a Clinician Needs to Know About Genome Editing: Status and Opportunities for Inborn Errors of Immunity;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

3. Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy;Immunological Reviews;2024-01-17

4. Gene Editing Approaches for Haematological Disorders;Comprehensive Hematology and Stem Cell Research;2024

5. Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4⁺ T‐cells for the treatment of Hyper IgM1;The EMBO Journal;2023-11-02